Skip to main content

Table 2 Univariate Cox regression analysis of CV risk factors and features of RA for risk of a time-dependent CV event among 232 patients

From: Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis

Risk factor Coefficient (β) SE Wald χ2 Risk ratio 95% CI Corrected pvalue a
Treatment with statins for hyperlipidemia -1.06 0.317 11.192 0.35 0.19–0.65 <0.01
Average prednisone dose of >10 mg/day 2.71 0.65 17.2 15.03 4.18–54.08 <0.01
RA disease duration (risk per year) -0.20 0.038 26.67 0.82 0.76–0.89 <0.01
  1. aBonferroni correction applied.
  2. Differences were tested by univariate Cox analysis, with the dependent variable time to event (from diagnosis of RA). CI, confidence interval; CV, cardiovascular; RA, rheumatoid arthritis; SE, standard error.